Ventyx Provides Clinical And Corporate Updates
Ventyx Biosciences Inc :VENTYX PROVIDES CLINICAL AND CORPORATE UPDATESVENTYX BIOSCIENCES INC: REVISING GUIDANCE FOR TOPLINE DATA RELEASE FROM INTERIM ANALYSIS OF PHASE 2 RP TRIAL TO Q1 2026
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments